Published in J Magn Reson Imaging on September 01, 2008
ESUR prostate MR guidelines 2012. Eur Radiol (2012) 8.86
Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology (2010) 2.38
Advancements in MR imaging of the prostate: from diagnosis to interventions. Radiographics (2011) 2.17
Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology (2011) 2.10
Amide proton transfer MR imaging of prostate cancer: a preliminary study. J Magn Reson Imaging (2011) 1.73
Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours. Eur Radiol (2011) 1.29
Multidisciplinary functional MR imaging for prostate cancer. Korean J Radiol (2009) 1.04
New agents and techniques for imaging prostate cancer. J Nucl Med (2009) 0.96
Radiotherapy planning using MRI. Phys Med Biol (2015) 0.93
Multiparametric magnetic resonance imaging of the prostate: current concepts. Radiol Bras (2015) 0.92
Simulated required accuracy of image registration tools for targeting high-grade cancer components with prostate biopsies. Eur Radiol (2012) 0.92
Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values. Eur Radiol (2012) 0.91
Pitfalls in Interpreting mp-MRI of the Prostate: A Pictorial Review with Pathologic Correlation. Insights Imaging (2015) 0.91
Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results. Eur Radiol (2010) 0.90
Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI. Eur Radiol (2012) 0.88
Standardization of multiparametric prostate MR imaging using PI-RADS. Biomed Res Int (2014) 0.88
Evaluation of short-TE (1)H MRSI for quantification of metabolites in the prostate. NMR Biomed (2014) 0.87
Performance of multiparametric magnetic resonance imaging in the evaluation and management of clinically low-risk prostate cancer. Urol Oncol (2013) 0.86
Can diffusion-weighted magnetic resonance imaging predict a high Gleason score of prostate cancer? Korean J Urol (2013) 0.86
The value of diffusion-weighted imaging in the detection of prostate cancer: a meta-analysis. Eur Radiol (2014) 0.85
Diffusion-weighted MR imaging in gynecologic cancers. J Gynecol Oncol (2011) 0.85
Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancer. Urol Oncol (2016) 0.84
3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study. Radiat Oncol (2013) 0.83
Increased signal intensity of prostate lesions on high b-value diffusion-weighted images as a predictive sign of malignancy. Eur Radiol (2013) 0.81
Integrating multiparametric prostate MRI into clinical practice. Cancer Imaging (2011) 0.81
Multi-parametric MR imaging of transition zone prostate cancer: Imaging features, detection and staging. World J Radiol (2010) 0.80
DW-MRI of the urogenital tract: applications in oncology. Cancer Imaging (2010) 0.77
Imaging and intervention in prostate cancer: Current perspectives and future trends. Indian J Radiol Imaging (2014) 0.76
The Correlation between Diffusion-Weighted Imaging and Histopathological Evaluation of 356 Prostate Biopsy Sites in Patients with Prostatic Diseases. ISRN Urol (2012) 0.76
Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy. World J Urol (2016) 0.76
The Utility of Diffusion Weighted Imaging (DWI) Using Apparent Diffusion Coefficient (ADC) Values in Discriminating Between Prostate Cancer and Normal Tissue. Pol J Radiol (2014) 0.76
Assessment of apparent diffusion coefficient values as predictor of aggressiveness in peripheral zone prostate cancer: comparison with Gleason score. ISRN Radiol (2014) 0.75
Comparison of T2(*) mapping with diffusion-weighted imaging in the characterization of low-grade vs intermediate-grade and high-grade prostate cancer. Br J Radiol (2016) 0.75
Application of an unsupervised multi-characteristic framework for intermediate-high risk prostate cancer localization using diffusion-weighted MRI. Magn Reson Imaging (2016) 0.75
Screening and Detection of Prostate Cancer-Review of Literature and Current Perspective. Indian J Surg Oncol (2017) 0.75
Amide proton transfer (APT) magnetic resonance imaging of prostate cancer: comparison with Gleason scores. MAGMA (2016) 0.75
Functional magnetic resonance imaging and molecular pathology at the crossroad of the management of early prostate cancer. World J Urol (2015) 0.75
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet (2006) 7.01
Accuracy in measurement of distance using limited cone-beam computerized tomography. Int J Oral Maxillofac Implants (2004) 2.14
An MRI-based atlas and database of the developing mouse brain. Neuroimage (2010) 1.99
Primary retroperitoneal neoplasms: CT and MR imaging findings with anatomic and pathologic diagnostic clues. Radiographics (2003) 1.90
Quantitative diffusion tensor tractography of the motor and sensory tract in children with cerebral palsy. Dev Med Child Neurol (2010) 1.87
Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk. J Clin Endocrinol Metab (2012) 1.74
Kidney function: glomerular filtration rate measurement with MR renography in patients with cirrhosis. Radiology (2011) 1.66
18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med (2006) 1.62
Symmetrical central tegmental tract (CTT) hyperintense lesions on magnetic resonance imaging in children. Eur Radiol (2008) 1.58
Multiple gastric ruptures caused by blunt abdominal trauma: report of a case. Surg Today (2002) 1.57
A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study. Bone (2011) 1.55
Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb (2006) 1.50
Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis. Magn Reson Imaging (2012) 1.46
Hip structural analysis: a comparison of DXA with CT in postmenopausal Japanese women. Springerplus (2013) 1.45
Cirrhosis: modified caudate-right lobe ratio. Radiology (2002) 1.32
Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS). Radiol Med (2015) 1.30
Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology (2008) 1.29
Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Urology (2008) 1.26
Diagnostic criteria for primary osteoporosis: year 2012 revision. J Bone Miner Metab (2013) 1.24
Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. J Control Release (2002) 1.18
P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier. Drug Metab Dispos (2007) 1.17
Direct transformation from amorphous to crystalline calcium phosphate facilitated by motif-programmed artificial proteins. Proc Natl Acad Sci U S A (2008) 1.17
Effect of low-repetition jump training on bone mineral density in young women. J Appl Physiol (1985) (2005) 1.15
Liliequist membrane: three-dimensional constructive interference in steady state MR imaging. Radiology (2003) 1.12
Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology (2008) 1.10
Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol (2007) 1.09
A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis. Bone (2009) 1.09
Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg (2005) 1.07
Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med (2006) 1.06
Creation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonist. J Biol Chem (2007) 1.06
Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging (2009) 1.05
Clinical Trials Express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (DIRECT). J Clin Endocrinol Metab (2014) 1.05
Age-related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues. J Magn Reson Imaging (2008) 1.03
Serum lipid survey and its recent trend in the general Japanese population in 2000. J Atheroscler Thromb (2005) 1.03
Benign or malignant?: differentiating breast lesions with computed tomography attenuation values on dynamic computed tomography mammography. J Comput Assist Tomogr (2005) 1.02
Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur J Radiol (2011) 1.00
Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies. Int J Pharm (2006) 0.99
Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia. Int J Urol (2011) 0.98
Cirrhosis or chronic hepatitis: evaluation of small (<or=2-cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology (2003) 0.97
MRI appearance of prostatic stromal sarcoma in a young adult. Korean J Radiol (2011) 0.96
Corticospinal tract localization: integration of diffusion-tensor tractography at 3-T MR imaging with intraoperative white matter stimulation mapping--preliminary results. Radiology (2006) 0.96
Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes. J Pharm Sci (2004) 0.95
Transperineal extended biopsy improves the clinically significant prostate cancer detection rate: a comparative study of 6 and 12 biopsy cores. Int J Urol (2006) 0.95
MR contrast of ferritin and hemosiderin in the brain: comparison among gradient-echo, conventional spin-echo and fast spin-echo sequences. Eur J Radiol (2003) 0.95
Radiofrequency ablated lesion in the normal porcine lung: long-term follow-up with MRI and pathology. Cardiovasc Intervent Radiol (2005) 0.95
The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin. J Control Release (2012) 0.95
Different signal intensities between intra- and extracranial components in jugular foramen meningioma: an enigma. AJNR Am J Neuroradiol (2005) 0.95
Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis. J Bone Miner Metab (2009) 0.94
T2-weighted MR imaging of prostate cancer: multishot echo-planar imaging vs fast spin-echo imaging. Eur Radiol (2003) 0.94
Diffusion-tensor fiber tractography: intraindividual comparison of 3.0-T and 1.5-T MR imaging. Radiology (2006) 0.94
Comparison of 3.0- and 1.5-T three-dimensional time-of-flight MR angiography in moyamoya disease: preliminary experience. Radiology (2006) 0.94
Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging. AJR Am J Roentgenol (2011) 0.93
Clinical features and genetic analysis of autosomal recessive hypercholesterolemia. J Clin Endocrinol Metab (2003) 0.93
SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer. Biochem Biophys Res Commun (2009) 0.93
Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium. AJR Am J Roentgenol (2011) 0.92
Evaluation of tris-acryl gelatin microsphere embolization with monochromatic X Rays: comparison with polyvinyl alcohol particles. J Vasc Interv Radiol (2006) 0.92
Drinking hydrogen water ameliorated cognitive impairment in senescence-accelerated mice. J Clin Biochem Nutr (2010) 0.92
Functional expression of metabotropic GABAB receptors in primary cultures of astrocytes from rat cerebral cortex. Biochem Biophys Res Commun (2006) 0.91
Radiofrequency ablation and immunostimulant OK-432: combination therapy enhances systemic antitumor immunity for treatment of VX2 lung tumors in rabbits. Radiology (2013) 0.91
Variation in synergistic activity by flavone and its related compounds on the increased susceptibility of various strains of methicillin-resistant Staphylococcus aureus to beta-lactam antibiotics. Int J Antimicrob Agents (2004) 0.91
Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trial. J Bone Miner Metab (2013) 0.91
Functional characterization of brain peptide transporter in rat cerebral cortex: identification of the high-affinity type H+/peptide transporter PEPT2. Brain Res (2004) 0.91
A uniqe antilipidemic drug--probucol. J Atheroscler Thromb (2008) 0.91
Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor. J Clin Oncol (2008) 0.91
Fecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan. Infect Drug Resist (2013) 0.91
Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution. Cardiovasc Intervent Radiol (2009) 0.90
CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma. Int J Cancer (2007) 0.90
Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats. Biol Pharm Bull (2007) 0.90
Gd-EOB-DTPA enhanced MR imaging: evaluation of biliary and renal excretion in normal and cirrhotic livers. Eur J Radiol (2010) 0.90
The short consensus repeats 1 and 2, not the cytoplasmic domain, of human CD46 are crucial for infection of subgroup B adenovirus serotype 35. J Control Release (2006) 0.90
Antioxidant and immuno-enhancing effects of Echinacea purpurea. Biol Pharm Bull (2004) 0.89
Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats. Int J Pharm (2008) 0.89
Anti-tumor activity of chemokine is affected by both kinds of tumors and the activation state of the host's immune system: implications for chemokine-based cancer immunotherapy. Biochem Biophys Res Commun (2004) 0.89
Fat-water interface on susceptibility-weighted imaging and gradient-echo imaging: comparison of phantoms to intracranial lipomas. AJR Am J Roentgenol (2013) 0.89